Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
The Lancet. Oncology
|
May 29, 2018
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy, Seock-Ah Im, Marco Colleoni, et al.
Respiratory Research
|
April 27, 2021
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
William Z Zhang, Katherine L Hoffman, Kristen T Schiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancer
Andreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
The Lancet. Oncology
|
May 29, 2018
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy, Seock-Ah Im, Marco Colleoni, et al.
Respiratory Research
|
April 27, 2021
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
William Z Zhang, Katherine L Hoffman, Kristen T Schiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancer
Andreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
Journal for Immunotherapy of Cancer
|
March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Page
of 9